Prevalence of Vitamin D Deficiency and Its Related Risk Factor in a Spanish Cohort of Adult HIV-Infected Patients: Effects of Antiretroviral Therapy

Authors:

Abstract
We analyzed serum 25(OH) cholecalciferol [25(OH)D] levels and factors related to deficiency (p=0.045). In multiple logistic regression, higher body mass index (BMI), black race/ethnicity, lower seasonal sunlight exposure, men who have sex with men (MSM), and heterosexual transmission categories, efavirenz exposure and lack of HIV viral suppression were independently associated with deficiency/insufficiency. These variables predicted 79% of cases [AUC=0.872 (95% CI, 0.83–0.91)]. Patients receiving protease inhibitors (PIs) [OR 4.0 (95% CI, 1.3–12.3); p=0.014] or NNRTI [OR 3.6 (95% CI, 1.7–11.2); p=0.025] had higher odds of increased PTH levels; this was significant only in 25(OH)D-deficient patients (p=0.004). As in less insolated areas, the prevalence of vitamin D deficiency/insufficiency was high in HIV-infected patients in Spain; among treated patients, levels were higher with PIs than with efavirenz.

This publication has 32 references indexed in Scilit: